Stockreport

Acorda Therapeutics misses by $0.44, beats on revenue [Seeking Alpha]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Acorda Therapeutics misses by $0.44, beats on revenueAcorda Therapeutics (NASDAQ:ACOR): Q4 EPS of $0.61misses by $0.44.Revenue of $188.4M (+34.0% Y/Y)beats by $16.68M.Pr [Read more]